ASX-listed Bapcor’s New Zealand portfolio includes the Midas and Battery Town brands, as well as wholesale channels.
Delays in US registration of Maxigesic IV has deferred licence income.
The hospitality business fell victim to Covid-19 and rising costs but was trading well in recent months.
NZX-listed insurer’s results announcement was delayed by ‘miserable glitch’.
Oceania Healthcare says focus on premium care suites is paying off.
Booking volumes continue to rise, but net loss widens.
Smartshares approaching $10b in funds under management under $31.25m acquisition.
Pent-up demand for used cars drives half-year revenue.
Interim revenue of $91 million is ahead of this time last year.
The company has until April 2023 to select either a preferred purchaser, equity investor or operator.